These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1540322)

  • 21. Respiratory insufficiency in the dog induced by pulmonary microembolism and inhibition of fibrinolysis. Effect of defibrinogenation, leucopenia and thrombocytopenia.
    Busch C; Lindquist O; Saldeen T
    Acta Chir Scand; 1974; 140(4):255-66. PubMed ID: 4837807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the kinetics of polynuclear cells after labeling "in vitro" with radioactive chromium. II. Results obtained in granulopenias].
    Dresch C; Najean Y; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(1):49-78. PubMed ID: 4226635
    [No Abstract]   [Full Text] [Related]  

  • 23. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxic hematologic side effects of chemotherapy: nursing interventions].
    Schewski R
    Pflege Z; 2009 Aug; 62(8):466-9. PubMed ID: 19728437
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug induced cytopenia with special reference to migration inhibition of mononuclear cells].
    Honetz N; Endler TA; Lackner J
    Haematol Blood Transfus; 1978; 21():423-31. PubMed ID: 738646
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites.
    Mueller-Eckhardt C; Salama A
    Transfus Med Rev; 1990 Jan; 4(1):69-77. PubMed ID: 2151995
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease].
    Robak T; Płuzańska A; Dmochowska M; Krykowski E; Oliskiewicz W; Fajndt S; Maciejczyk J; Jabłkowski W; Mazurowa A
    Acta Haematol Pol; 1982; 13(1-2):5-11. PubMed ID: 7180356
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increased apoptosis of peripheral blood leukocytes correlates with leukopenia after high-dose chemotherapy].
    Chukhlovin AB
    Vopr Onkol; 1999; 45(4):384-6. PubMed ID: 10532096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group.
    Chemioterapia; 1986 Apr; 5(2):134-9. PubMed ID: 2871945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
    Yamashita J; Kawamura T; Shoin K
    No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
    [No Abstract]   [Full Text] [Related]  

  • 33. Early-onset leukopenia and severe thrombocytopenia following doxorubicin chemotherapy for tonsillar squamous cell carcinoma in a dog.
    Henry CJ; Brewer WG; Stutler SA
    Cornell Vet; 1993 Apr; 83(2):163-8. PubMed ID: 8467702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of the effect of rubomycin C and B on peripheral blood of animals].
    Vertogradova TP
    Antibiotiki; 1969 Sep; 14(9):840-5. PubMed ID: 5361829
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of a multicenter, phase-II clinical trial of Dicarbamin used to shield leukopoiesis in cancer patients with immunosuppression due to chemotherapy].
    Garin AM; Gorbunova VA; Bychkov MB; Mindra NV; Stenina MB; Topchieva SV; Treshchalina EM; Chitiia LV; Sdvizhkov AM; Borisov VI; Gurov SN; Gershanovich ML; Makhnova EV; Nebol'sin VE
    Vopr Onkol; 2004; 50(2):184-8. PubMed ID: 15176221
    [No Abstract]   [Full Text] [Related]  

  • 36. Reticulated platelets in the evaluation of thrombopoietic disorders.
    Rinder HM; Munz UJ; Ault KA; Bonan JL; Smith BR
    Arch Pathol Lab Med; 1993 Jun; 117(6):606-10. PubMed ID: 8503732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endotoxin effect].
    Fritsch H
    Fortschr Med; 1972 Sep; 90(27):989-92. PubMed ID: 4653174
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).
    Hansen HH; Selawry OS; Muggia FM; Walker MD
    Cancer Res; 1971 Mar; 31(3):223-7. PubMed ID: 4926242
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Vaquez's polycythemia with 1-4, bis-3-bromopropionyl-piperazine. Study of 36 cases].
    Bilski-Pasquier G; Blanc CM; Bousser J
    Presse Med (1893); 1968 Oct; 76(41):1953-6. PubMed ID: 5248051
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing chemotherapy-induced bone marrow suppression in cancer.
    Lokich JJ
    Hosp Pract; 1976 Aug; 11(8):61-7. PubMed ID: 1027711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.